Plt
Zurich, CH · 1 known investors
Develops a space-based biotechnology process to produce human tissue organoids from autologous mesenchymal stem cells in microgravity, along with custom hardware for commercial-scale organoid production. Its organoids target pharmaceutical research and testing, precision medicine, and transplantation-based therapies.
Investors · 1
Frequently asked questions
- What does Plt do?
- Develops a space-based biotechnology process to produce human tissue organoids from autologous mesenchymal stem cells in microgravity, along with custom hardware for commercial-scale organoid production. Its organoids target pharmaceutical research and testing, precision medicine, and transplantation-based therapies.
- Who are Plt's investors?
- Plt's investors include E2MC Ventures.
- Where is Plt headquartered?
- Plt is headquartered in Zurich, CH.